Advertisement
Advertisement

BHC

BHC logo

Bausch Health Companies Inc

6.32
USD
Sponsored
+0.02
+0.32%
Aug 28, 15:59 UTC -4
Closed
exchange

After-Market

6.33

+0.01
+0.16%

Bausch Health Companies Inc Profile

About

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.

Info & Links

CEO

Thomas J. Appio

Headquarters

2150 ST. ELZEAR BLVD. WEST
QUEBEC, A8 H7L 4A8, CANADA

Industry

Medical Generic Drugs

Sector

Medical

Website

www.bauschhealth.com

Auditor

PricewaterhouseCoopers LLP

Share holders

1,737

Employees

20,300

Bausch Health Companies Inc Statistics

Valuation Measures

Market Capitalization2

2.37B

Enterprise Value

21.31B

Enterprise Value/EBITDA(ttm)

10.01

Price to Earnings Ratio(ttm)

1.47

Price to Sales(ttm)

0.22

Price to Book(mrq)

--

Price to Cash(ytd)

0.86

Profitability

Gross Margin(ttm)

71.79%

Operating Margin(ttm)

14.90%

Profit Margin(ttm)

-11.17%

Return on Equity(ttm)

-561.95%

Return on Invested Capital(ttm)

-5.87%

Return on Assets(ttm)

6.31%

Income Statement

Revenue(ttm)

10.85B

Revenue Per Share(ttm)

29.02

Gross Profit(ttm)

7.79B

EBITDA(ttm)3

2.13B

Net Income Available to Common(ttm)

-1.10B

Diluted EPS(ttm)

-2.96

Share Statistics

Beta (5Y Monthly)

0.38

52-Week Change

-11.61%

S&P 500 52-Week Change

19.58%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

373.99M

Dividend Yield

0.00%

Float4

296.80M

% Held by Insiders

20.67%

% Held by Institutions

78.65%

Balance Sheet

Total Cash(mrq)

1.84B

Total Cash Per Share(mrq)

4.91

Total Debt(mrq)

20.78B

Total Debt/Equity(mrq)

-2590.90%

Current Ratio(mrq)

1.44%

Quick Ratio(mrq)

1.08%

Book Value Per Share(mrq)

-2.15

Cash Flow

Operating Cash Flow Per Share(ytd)

2.38

Free Cash Flow(ytd)

714.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement